ATE550668T1 - Verfahren zur identifizierung von patienten mit erhöhtem risiko für ein unerwünschtes herz- kreislauf-ereignis - Google Patents

Verfahren zur identifizierung von patienten mit erhöhtem risiko für ein unerwünschtes herz- kreislauf-ereignis

Info

Publication number
ATE550668T1
ATE550668T1 AT07799096T AT07799096T ATE550668T1 AT E550668 T1 ATE550668 T1 AT E550668T1 AT 07799096 T AT07799096 T AT 07799096T AT 07799096 T AT07799096 T AT 07799096T AT E550668 T1 ATE550668 T1 AT E550668T1
Authority
AT
Austria
Prior art keywords
cardiovascular event
adverse cardiovascular
platelet
increased risk
identifying patients
Prior art date
Application number
AT07799096T
Other languages
English (en)
Inventor
Douglas Christie
Original Assignee
Siemens Healthcare Diagnostics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Healthcare Diagnostics filed Critical Siemens Healthcare Diagnostics
Application granted granted Critical
Publication of ATE550668T1 publication Critical patent/ATE550668T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
AT07799096T 2006-07-07 2007-06-27 Verfahren zur identifizierung von patienten mit erhöhtem risiko für ein unerwünschtes herz- kreislauf-ereignis ATE550668T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/483,028 US7935498B2 (en) 2006-07-07 2006-07-07 Methods for identifying patients with increased risk of an adverse cardiovascular event
PCT/US2007/072256 WO2008005771A2 (en) 2006-07-07 2007-06-27 Methods for identifying patients with increased risk of an adverse cardiovascular event

Publications (1)

Publication Number Publication Date
ATE550668T1 true ATE550668T1 (de) 2012-04-15

Family

ID=38895327

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07799096T ATE550668T1 (de) 2006-07-07 2007-06-27 Verfahren zur identifizierung von patienten mit erhöhtem risiko für ein unerwünschtes herz- kreislauf-ereignis

Country Status (6)

Country Link
US (1) US7935498B2 (de)
EP (1) EP2044212B1 (de)
JP (1) JP5140075B2 (de)
AT (1) ATE550668T1 (de)
ES (1) ES2384651T3 (de)
WO (1) WO2008005771A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010039988A1 (en) * 2008-10-01 2010-04-08 The Johns Hopkins University Thromboxane generation analysis for cardiovascular events
WO2010058412A1 (en) * 2008-11-19 2010-05-27 Dilip Shrinivas Velaskar A new rapid thrombochek test kit based on whole blood screening test to detect platelet hyperaggregation at a temparature of 37°c in the clinical laboratory
JP2010261790A (ja) * 2009-05-01 2010-11-18 Takemichi Kanazawa 血管障害の素因の検査方法、及び治療法の選択方法
AU2012229156A1 (en) 2011-03-11 2013-10-31 Board Of Regents Of The University Of Nebraska Biomarker for coronary artery disease
EP2525228A1 (de) * 2011-05-18 2012-11-21 Siemens Healthcare Diagnostics Products GmbH Verfahren zur Bestimmung des Risikos einer Clopidogrel-Resistenz
JP6319308B2 (ja) * 2012-07-06 2018-05-09 Jnc株式会社 合成コラーゲンを用いる、アスピリン応答および反応性試験、ならびにアスピリンコンプライアンス試験
WO2014039859A1 (en) 2012-09-06 2014-03-13 Duke University Diagnostic markers for platelet function and methods of use

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57552A (en) * 1980-06-03 1982-01-05 Kowa Co Method for measuring agglutination power of blood platelet and kit for measuring agglutination power of bood platelet
US5688768A (en) * 1991-02-19 1997-11-18 Cor Therapeutics, Inc. Recombinant thrombin receptor and related pharmaceuticals
US5256538A (en) * 1991-03-08 1993-10-26 Board Of Regents, The University Of Texas System Detection of early platelet activation and prediagnosis of thrombotic events
US6210877B1 (en) * 1997-03-10 2001-04-03 Interleukin Genetics, Inc. Prediction of coronary artery disease
US6410337B1 (en) * 1997-09-18 2002-06-25 Helena Laboratories Corporation Method of platlet function analysis using platelet count
SE9802402D0 (sv) * 1998-07-03 1998-07-03 Karolinska Innovations Ab Method of diagnosing cardiovascular disease and early atherosclerosis
US6994983B2 (en) * 1999-10-25 2006-02-07 Esoterix, Inc. Coagulation Kits for determination of thromboxane B2 metabolite and optimizing aspirin dosage
ATE458199T1 (de) * 2001-05-04 2010-03-15 Biosite Inc Diagnostische marker der akuten koronaren syndrome und ihre verwendungen
US20030100036A1 (en) * 2001-11-08 2003-05-29 Aristo Vojdani Saliva immunoassay for detection of antibodies for cardiovascular disease
US20040131500A1 (en) * 2002-01-18 2004-07-08 Chow Herbert S. Device and method for evaluating platelets
WO2003081236A2 (en) * 2002-03-24 2003-10-02 Mcmaster University Method and device for predicting cardiovascular events
DE10221054A1 (de) * 2002-05-10 2003-11-27 Michael Kratzer Verfahren zur Untersuchung der Thrombozytenfunktion des Blutes
AU2003267147A1 (en) * 2002-09-10 2004-04-30 Placor, Inc. Method and device for monitoring platelet function
AU2003277398A1 (en) * 2002-10-15 2004-05-04 The University Of Tennessee Research Foundation Methods for assessment of platelet aggregation
US20050181386A1 (en) * 2003-09-23 2005-08-18 Cornelius Diamond Diagnostic markers of cardiovascular illness and methods of use thereof
US20050123451A1 (en) * 2003-10-31 2005-06-09 Hiroshi Nomura System and apparatus for body fluid analysis using surface-textured optical materials
US20050255534A1 (en) * 2004-05-14 2005-11-17 Ericson Daniel G Method and device for monitoring asprin response

Also Published As

Publication number Publication date
ES2384651T3 (es) 2012-07-10
US7935498B2 (en) 2011-05-03
WO2008005771A3 (en) 2008-12-11
JP2009543063A (ja) 2009-12-03
WO2008005771A2 (en) 2008-01-10
US20080009024A1 (en) 2008-01-10
JP5140075B2 (ja) 2013-02-06
EP2044212A2 (de) 2009-04-08
EP2044212A4 (de) 2009-07-01
EP2044212B1 (de) 2012-03-21

Similar Documents

Publication Publication Date Title
ATE550668T1 (de) Verfahren zur identifizierung von patienten mit erhöhtem risiko für ein unerwünschtes herz- kreislauf-ereignis
ATE548467T1 (de) Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände
WO2011079938A3 (en) System and method for determining the concentration of an analyte in a sample fluid
ATE493649T1 (de) Verfahren zur diagnose von polyzystischer nierenkrankheit
ATE518007T1 (de) Verfahren und vorrichtung zur korrelierung der ebenen von biomarker-produkten mit erkrankungen
WO2012120546A3 (en) Method for monitoring anticoagulant therapy
ATE536553T1 (de) Verfahren zum nachweis grösserer ungünstiger kardiovaskulärer und zerebrovaskulärer ereignisse
BRPI0515391A (pt) métodos para ensaio de uma carga de alimentação contendo hidrocarboneto e para ensaio de um óleo cru
WO2014066913A8 (en) Health diagnostic systems and methods
BRPI0715126B8 (pt) métodos para avaliação do risco de intervenções cardíacas e usos à base de gdf-15
NZ592358A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure using tissue inhibitor of metalloproteinase 2 (timp-2)
MX2009013093A (es) Metodos y aparatos para medir coagulacion de la sangre.
WO2012018535A3 (en) Wellness panel
ATE473446T1 (de) Verfahren und testvorrichtungen zur unterscheidung verschiedener formen von krankheiten und leiden, die durch thrombocytopenia und/oder durch spontane interaktionen zwischen dem von-willebrand-faktor und plättchen gekennzeichnet sind
DE602007013263D1 (de) Verfahren und mittel zur bestimmung der blutplättchenfunktion und zur diagnose von mit blutplättchenngen
ATE537454T1 (de) Verfahren zum beurteilen von herzinsuffizienz bei patienten mit vorhofflimmern mittels gdf-15
BRPI0709271B8 (pt) métodos para a detecção de uma doença renal
ATE514951T1 (de) Verfahren zur prüfung eines mehrkanaligen elements zur blutanalyse
WO2006001813A3 (en) Macrophage migration inhibitory factor as a marker for cardiovascular risk
MX2009006744A (es) Panel de padecimiento cardiovascular autoinmune y metodos de utilizacion del mismo.
ATE426175T1 (de) Verfahren zur standardisierung von gerinnungstesten
BR112015021507A8 (pt) métodos e composições para o diagnóstico de pré-eclampsia em uma mulher grávida e kit de ensaio de diagnóstico
ATE470862T1 (de) Vorrichtung und verfahren zur unterscheidung zwischen akuter und chronischer myokardial- nekrose bei symptomatischen patienten
JP2019510974A5 (de)
NZ599054A (en) Diagnosis of collagen IX destruction